EVROFARMA S.A. (CR)EVROFARMA S.A. (CR)EVROFARMA S.A. (CR)

EVROFARMA S.A. (CR)

No trades
See on Supercharts
Market capitalization
‪19.35 M‬EUR
‪2.20 M‬EUR
‪45.38 M‬EUR
‪8.42 M‬
Beta (1Y)
1.26

About EVROFARMA S.A. (CR)


CEO
Athanasios Christou Papazilakis
Headquarters
Orestiada
Founded
1991
ISIN
GRS385113006
FIGI
BBG000BX68F4
Evrofarma SA engages in the production of milk and dairy products. The company was founded by Athanasios Papazilakis and Paschalis Papazilakis on July 17, 1991 and is headquartered in Orestiada, Greece.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EVROF is 1.400 EUR — it has decreased by −2.47% in the past 24 hours. Watch EVROFARMA S.A. (CR) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ATHEX exchange EVROFARMA S.A. (CR) stocks are traded under the ticker EVROF.
EVROF stock has fallen by −1.43% compared to the previous week, the month change is a −10.97% fall, over the last year EVROFARMA S.A. (CR) has showed a 55.56% increase.
EVROF reached its all-time high on Aug 5, 2003 with the price of 3.380 EUR, and its all-time low was 0.120 EUR and was reached on Mar 10, 2016. View more price dynamics on EVROF chart.
See other stocks reaching their highest and lowest prices.
EVROF stock is 1.43% volatile and has beta coefficient of 1.26. Track EVROFARMA S.A. (CR) stock price on the chart and check out the list of the most volatile stocks — is EVROFARMA S.A. (CR) there?
Today EVROFARMA S.A. (CR) has the market capitalization of ‪19.35 M‬, it has decreased by −1.39% over the last week.
Yes, you can track EVROFARMA S.A. (CR) financials in yearly and quarterly reports right on TradingView.
EVROF net income for the last half-year is ‪1.40 M‬ EUR, while the previous report showed ‪660.00 K‬ EUR of net income which accounts for 112.27% change. Track more EVROFARMA S.A. (CR) financial stats to get the full picture.
Yes, EVROF dividends are paid annually. The last dividend per share was 0.05 EUR. As of today, Dividend Yield (TTM)% is 3.53%. Tracking EVROFARMA S.A. (CR) dividends might help you take more informed decisions.
EVROFARMA S.A. (CR) dividend yield was 4.17% in 2023, and payout ratio reached 31.06%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, EVROF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EVROFARMA S.A. (CR) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EVROFARMA S.A. (CR) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EVROFARMA S.A. (CR) stock shows the buy signal. See more of EVROFARMA S.A. (CR) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.